Chemoinformaics analysis of 2-METHYL-5-[(2R)-6-METHYLHEPT-5-EN-2-YL]PHENOL
Molecular Weight | 218.34 | nRot | 4 |
Heavy Atom Molecular Weight | 196.164 | nRig | 31 |
Exact Molecular Weight | 218.167 | nRing | 1 |
Solubility: LogS | -2.293 | nHRing | 0 |
Solubility: LogP | 0.937 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 40.5214 |
nHD | 1 | BPOL | 22.0706 |
QED | 0.681 |
Synth | 6.58 |
Natural Product Likeliness | 2.026 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.014 |
Pgp-sub | 0.006 |
HIA | 0.28 |
CACO-2 | -4.998 |
MDCK | 0.0000198 |
BBB | 0.903 |
PPB | 0.31528 |
VDSS | 1.467 |
FU | 0.711328 |
CYP1A2-inh | 0.006 |
CYP1A2-sub | 0.755 |
CYP2c19-inh | 0.028 |
CYP2c19-sub | 0.948 |
CYP2c9-inh | 0.021 |
CYP2c9-sub | 0.499 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.587 |
CYP3a4-inh | 0.053 |
CYP3a4-sub | 0.931 |
CL | 6.066 |
T12 | 0.106 |
hERG | 0.03 |
Ames | 0.016 |
ROA | 0.979 |
SkinSen | 0.076 |
Carcinogencity | 0.948 |
EI | 0.009 |
Respiratory | 0.913 |
NR-Aromatase | 0.884 |
Antiviral | Yes |
Prediction | 0.833341 |